Saba Capital Management, L.P. and reporting person Boaz Weinstein reported an acquisition of Common Stock of Gabelli Healthcare & WellnessRx Trust (GRX). On 08/25/2025 they purchased 11,330 shares at $9.48 per share, and the filing shows 2,037,156 shares beneficially owned indirectly following the transaction. The Form 4 is signed and dated 08/26/2025 by Saba Capital and Boaz Weinstein.
The filing reports that Saba Capital Management, L.P. and Boaz Weinstein, both identified as a director and 10% owner, purchased 19,101 shares of Gabelli Healthcare & WellnessRx Trust (GRX) on 08/21/2025 at a price of $9.43 per share. After the transaction, the reporting persons are shown as beneficially owning 2,025,826 shares indirectly. The Form 4 reflects a routine insider purchase disclosed under Section 16.